A manager at the Alpha Biotech Corporation claimed that the research costs for new treatments requested by the health department should be funded by the government, arguing that the sales of treatments are expected to be less lucrative than those of other medical products. The manager supported this claim by stating that treatments are typically used multiple times by patients, while vaccines are given only once. Which one of the following, if true, most undermines the manager's argument regarding the sales of treatments?